Hepatic epithelioid haemangioendothelioma (HEHE) is a rare, low to intermediate grade malignant hepatic vascular tumour.
There may be a greater female incidence (with reported male-to-female ratio, 3:2), with peak incidence thought to be around 30-40 year-old.
Histologically, the tumours are composed of dendritic and epithelioid cells. Tumour cells with intracytoplasmic lumina, occasionally containing red blood cells, appear as signet ring-like structures 2. They can be difficult to diagnose on the basis of biopsy results.
They tend to be multiple solid tumour nodules, located in a predominantly peripheral distribution, which coalescence to individual nodules. Lesions adjacent to the capsule often produce hepatic capsular retraction.
Usually seen as hepatic lesions that are predominantly hypoechoic; however, hepatic lesions can also have mixed echotexture or be predominantly hyperechoic.
Typically seen as multiple hypoattenuating lesions in both hepatic lobes that coalesce to form larger confluent hypoattenuating regions in a peripheral or subcapsular distribution, with a halo or target pattern of enhancement in larger lesions. Subcapsular lesions often present with capsular retraction.
Calcifications are uncommon, but do occur on occasion.
- T1: hypointense lesions relative to normal liver parenchyma on unenhanced T1-weighted images
- T2: heterogeneously increased signal intensity.
- C+ (Gd): some lesions demonstrate either a peripheral halo or a target-type enhancement pattern after administration of a gadolinium-based contrast agent, with an occasional thin peripheral hypointense rim.
Ferumoxides-enhanced T2-weighted images may help physicians distinguish tumour margins
Treatment and prognosis
The clinical course of these lesions can be variable with histologic analysis being of little value in predicting the clinical outcome 1. The overall prognosis is much more favourable than other hepatic malignancies 4.
Radical surgical resection or orthoptic liver transplantation are considered the treatments of choice 1,4. Due to the often multifocal nature of the tumour, transplantation may be the optimal treatment. Metastatic lesions have been reported in ~30% of patients at presentation and occur most commonly in the lungs 7. Other less common sites include the abdominal lymph nodes, omentum, mesentery, and peritoneum.
- 1. Earnest F, Johnson CD. Case 96: Hepatic epithelioid hemangioendothelioma. Radiology. 2006;240 (1): 295-8. doi:10.1148/radiol.2401032099 - Pubmed citation
- 2. Lyburn ID, Torreggiani WC, Harris AC et-al. Hepatic epithelioid hemangioendothelioma: sonographic, CT, and MR imaging appearances. AJR Am J Roentgenol. 2003;180 (5): 1359-64. AJR Am J Roentgenol (full text) - Pubmed citation
- 3. Radin DR, Craig JR, Colletti PM et-al. Hepatic epithelioid hemangioendothelioma. Radiology. 1988;169 (1): 145-8. Radiology (abstract) - Pubmed citation
- 4. Läuffer JM, Zimmermann A, Krähenbühl L et-al. Epithelioid hemangioendothelioma of the liver. A rare hepatic tumor. Cancer. 1996;78 (11): 2318-27. - Pubmed citation
- 5. Furui S, Itai Y, Ohtomo K et-al. Hepatic epithelioid hemangioendothelioma: report of five cases. Radiology. 1989;171 (1): 63-8. Radiology (abstract) - Pubmed citation
- 6. Miller WJ, Dodd GD, Federle MP et-al. Epithelioid hemangioendothelioma of the liver: imaging findings with pathologic correlation. AJR Am J Roentgenol. 1992;159 (1): 53-7. AJR Am J Roentgenol (abstract) - Pubmed citation
- 7. Makhlouf HR, Ishak KG, Goodman ZD. Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases. Cancer. 1999;85 (3): 562-82. - Pubmed citation